Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gala Health vs Valhalla Vitality

Gala Health
Graded #17

Higher grade

vs+19.300000000000004
Valhalla Vitality
Graded #253

Lower grade

The verdict

Gala Health takes it — 82.9/100 to 63.6/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGala Health +48
84
36
Dose & formulationGala Health +19
83
64
Clinical oversightGala Health +3
85
82
Labs & monitoringEven
83
83
FulfillmentGala Health +21
88
67
Contract termsGala Health +5
66
61
Gala Health · left barValhalla Vitality · right bar

The numbers

MetricGala HealthValhalla Vitality
WeighScore82.9/10063.6/100
GradeB−C
Scorecard rank#17#253
SemaglutideNot disclosed$449/mo (compounded)
Tirzepatide$179/mo (yearly subscription)$449/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Gala Health

Graded #17 · B−

Strengths

  • Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
  • Prices are published openly rather than quiz-gated, with all doses included at the one rate
  • All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet — injection only
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy
Valhalla Vitality

Graded #253 · C

Strengths

  • LegitScript-certified pharmacy partner
  • Offers both compounded semaglutide and tirzepatide
  • No membership fees and free consultations
  • Add-on peptide and hormone therapies plus at-home labs

Where it loses points

  • Compounded GLP-1 only, no FDA-approved branded options
  • Pricing not transparently listed on the main site
  • Compounded drugs are not FDA-approved for safety or efficacy
  • States served not clearly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard